Received May 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
cardiac arrest; GBS/could not talk/lost control of legs; This serious case was reported by a consumer via interactive digital media and described the occurrence of cardiac arrest in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. In JUN-2022, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced cardiac arrest (Verbatim: cardiac arrest) (serious criteria hospitalization, GSK medically significant and life threatening) and guillain barre syndrome (Verbatim: GBS/could not talk/lost control of legs) (serious criteria hospitalization and GSK medically significant). The outcome of the cardiac arrest and guillain barre syndrome were not reported. The reporter considered the cardiac arrest and guillain barre syndrome to be related to Shingles vaccine. The company considered the cardiac arrest and guillain barre syndrome to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 19-APR-2025 This case was reported by a patient via interactive digital media. Patient took the first shot in June of 2022 and 10 days later lost control of legs and went to emergency room. Patient came down with the worst side effects of shot Guillain Barre syndrome and spent 6 weeks in the hospital, one week in ICU. Patient went into cardiac arrest and almost died and was completely paralyzed and could not talk. Patient stated that it was from the shot and was done with all shots.; Sender's Comments: Cardiac arrest and Guillain-Barre syndrome are unlisted events which are considered unrelated to GSK vaccine Shingles vaccine.